Hear.com Horizon Go IX vs Signia Pure C&G BCT IX
Side-by-side HearAdvisor lab results with SoundGrades, expert pick badges, and the same visualizations we use in product reviews.
Choice

Hear.com Horizon Go IX
The Hear.com Horizon Go IX is a premium prescription behind-the-ear hearing aid released in 2024, priced at $6,500. In HearAdvisor's lab testing, it earned an A grade with a SoundScore of 4.4/5, ranking #19 among 39 prescription hearing aids tested. Speech performance is a clear strength for the Horizon Go IX. It scores 4.0/5 in speech-in-quiet conditions—0.64 points above the category average—delivering strong audibility in conversational settings. Speech-in-noise performance also exceeds the category average by 0.46 points, though at 2.6/5 the absolute score remains mixed, meaning challenging listening environments may still pose difficulties. Own-voice comfort is the device's most notable weakness, scoring just 1.8/5—a low result that falls 0.90 points below the category average. Users sensitive to how their own voice sounds may find this limiting. Feedback handling scores 4.4/5, which is strong in absolute terms, though slightly below the category average of 4.72/5. Music streaming performance is essentially average at 2.7/5. At this price point, shoppers face stiff competition. Several alternatives in the same premium tier—including the Phonak Sphere Infinio, Oticon Intent, and Widex Allure RIC 440—deliver higher overall scores. Devices like the Rexton Reach R-Li T80 at Costco offer comparable or better sound performance at lower prices. The Horizon Go IX is best suited for users who prioritize speech clarity and have access to this product through hear.com's network, but those flexible on brand should compare alternatives before committing.
Choice

Signia Pure C&G BCT IX
The Signia Pure C&G BCT IX is a premium behind-the-ear prescription hearing aid released in 2025, earning an A grade with a SoundScore of 4.4/5 in our lab testing. Priced at $3,398, it ranks #16 among 39 prescription hearing aids tested. In our standardized testing, this device demonstrates particular strength in own-voice comfort, scoring 3.8/5—a solid result that sits 1.10 points above the category average. This makes it a noteworthy option for users who prioritize natural sound quality when speaking. Speech clarity also performs well, with speech-in-quiet at 3.8/5 (+0.39 points above average) and speech-in-noise at 2.5/5 (+0.43 points above average), though the latter remains mixed in absolute terms despite beating the category benchmark. Feedback handling presents an interesting picture: at 4.2/5, it's strong in absolute terms, though it falls 0.52 points below the category average of 4.72/5. Music streaming scores 2.7/5, essentially matching the category average. The device features rechargeable batteries, iPhone and Android streaming, and hands-free functionality. While the Pure C&G BCT IX delivers solid overall performance, shoppers in this premium price tier should note that competitors like the Phonak Sphere Infinio and Oticon Intent score higher in our testing. Budget-conscious buyers may also find comparable sound quality at lower price points from options like the Rexton Reach R-Li T80 at Costco. This hearing aid is best suited for users who value own-voice naturalness and reliable speech clarity in everyday listening situations.
We independently review each item we recommend and appreciate your trust and support. When you buy through our links, we may earn a commission. Learn More.
Performance metrics
Scale 1-5 (Tuned)
Lab metric by fit
Scale 1-5 (Tuned)
Speech level
Adjust input dB (Tuned)
Amplification (REIG)
Insertion gain at 65 dB (Tuned)
Fitting configuration for tuned fit